Filing Details
- Accession Number:
- 0001209191-21-018815
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-09 06:00:16
- Reporting Period:
- 2021-03-08
- Accepted Time:
- 2021-03-09 06:00:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1394319 | Tracon Pharmaceuticals Inc. | TCON | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789822 | B. Scott Brown | C/O Tracon Pharmaceuticals, Inc. 4350 La Jolla Village Drive, Suite 800 San Diego CA 92122 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-08 | 1,000 | $8.30 | 3,128 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.28 to $8.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- Includes 350 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on each of April 20, 2020 and October 20, 2020.
Billionaire Hedge Funds
